Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma.
作者信息
Sakai Chio, Matsuyama Masashi, Nakajima Masayuki, Matsumura Sosuke, Nonaka Mizu, Arai Naoki, Kuramoto Kenya, Yoshida Kazufumi, Morishima Yuko, Muratani Masafumi, Hizawa Nobuyuki
机构信息
Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
出版信息
Allergol Int. 2024 Jul;73(3):473-476. doi: 10.1016/j.alit.2024.03.005. Epub 2024 Apr 6.
PMID:38582716
Abstract
摘要
相似文献
1
Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma.
Allergol Int. 2024 Jul;73(3):473-476. doi: 10.1016/j.alit.2024.03.005. Epub 2024 Apr 6.
2
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype.
J Allergy Clin Immunol. 2019 Nov;144(5):1336-1342.e7. doi: 10.1016/j.jaci.2019.08.005. Epub 2019 Aug 16.
3
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
Ann Am Thorac Soc. 2014 May;11(4):531-6. doi: 10.1513/AnnalsATS.201310-354OC.
4
Benralizumab strongly reduces blood basophils in severe eosinophilic asthma.
Clin Exp Allergy. 2020 Nov;50(11):1267-1269. doi: 10.1111/cea.13720. Epub 2020 Aug 26.
5
Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
Clin Exp Allergy. 2016 Jun;46(6):793-802. doi: 10.1111/cea.12695.
6
Proportion of Severe Asthma Patients Eligible for Mepolizumab Therapy by Age and Age of Onset of Asthma.
J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2689-2696.e2. doi: 10.1016/j.jaip.2019.05.053. Epub 2019 Jun 13.
7
Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis.
BMC Pulm Med. 2019 Oct 12;19(1):176. doi: 10.1186/s12890-019-0952-1.
8
A real-life cohort of mepolizumab treatment in severe eosinophilic asthma.
Eur Ann Allergy Clin Immunol. 2024 Jul;56(4):169-175. doi: 10.23822/EurAnnACI.1764-1489.289. Epub 2023 Mar 16.
9
Early decreases in blood eosinophil levels with reslizumab.
J Allergy Clin Immunol. 2019 Apr;143(4):1653-1655. doi: 10.1016/j.jaci.2018.12.997. Epub 2019 Jan 14.
10
Reslizumab (Cinqair) for severe eosinophilic asthma.
Med Lett Drugs Ther. 2016 Jun 20;58(1497):81-2.
Zotero 插件